Targeting αV-integrins decreased metastasis and increased survival in a nude rat breast cancer brain metastasis model
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting αV-integrins decreased metastasis and increased survival in a nude rat breast cancer brain metastasis model
Authors
Keywords
-
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 110, Issue 1, Pages 27-36
Publisher
Springer Nature
Online
2012-07-28
DOI
10.1007/s11060-012-0942-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cyclophosphamide Enhances Human Tumor Growth in Nude Rat Xenografted Tumor Models
- (2015) Yingjen Jeffrey Wu et al. NEOPLASIA
- Targeting of αv-Integrins in Stem/Progenitor Cells and Supportive Microenvironment Impairs Bone Metastasis in Human Prostate Cancer
- (2015) Geertje van der Horst et al. NEOPLASIA
- Defining the Role of Integrin αvβ6 in Cancer
- (2012) A. Bandyopadhyay et al. CURRENT DRUG TARGETS
- Integrin αv Expression Is Required for the Acquisition of a Metastatic Stem/Progenitor Cell Phenotype in Human Prostate Cancer
- (2011) Christel van den Hoogen et al. AMERICAN JOURNAL OF PATHOLOGY
- A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma
- (2011) S O'Day et al. BRITISH JOURNAL OF CANCER
- Anti- v Integrin Monoclonal Antibody Intetumumab Enhances the Efficacy of Radiation Therapy and Reduces Metastasis of Human Cancer Xenografts in Nude Rats
- (2010) S. Ning et al. CANCER RESEARCH
- Heterogeneous Blood-Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
- (2010) P. R. Lockman et al. CLINICAL CANCER RESEARCH
- Cilengitide inhibits progression of experimental breast cancer bone metastases as imaged noninvasively using VCT, MRI and DCE-MRI in a longitudinal in vivo study
- (2010) Tobias Bäuerle et al. INTERNATIONAL JOURNAL OF CANCER
- A phase 1, multicenter, open-label study of the safety of two dose levels of a human monoclonal antibody to human αv integrins, intetumumab, in combination with docetaxel and prednisone in patients with castrate-resistant metastatic prostate cancer
- (2010) Franklin M. Chu et al. INVESTIGATIONAL NEW DRUGS
- Dynamic magnetic resonance imaging assessment of vascular targeting agent effects in rat intracerebral tumor models
- (2010) L. L. Muldoon et al. NEURO-ONCOLOGY
- An integrin αvβ3–c-Src oncogenic unit promotes anchorage-independence and tumor progression
- (2009) Jay S Desgrosellier et al. NATURE MEDICINE
- Activation of tumor cell integrin v 3 controls angiogenesis and metastatic growth in the brain
- (2009) M. Lorger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- v 6 Integrin Promotes the Invasion of Morphoeic Basal Cell Carcinoma through Stromal Modulation
- (2008) D. Marsh et al. CANCER RESEARCH
- Inhibition of Metastatic Outgrowth from Single Dormant Tumor Cells by Targeting the Cytoskeleton
- (2008) D. Barkan et al. CANCER RESEARCH
- Cilengitide: an integrin-targeting arginine–glycine–aspartic acid peptide with promising activity for glioblastoma multiforme
- (2008) David A Reardon et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Effect of Lapatinib on the Outgrowth of Metastatic Breast Cancer Cells to the Brain
- (2008) B. Gril et al. JNCI-Journal of the National Cancer Institute
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search